INTRODUCTION
Degeneration of dopaminergic neurons in the substantia nigra (SN) and dopaminecontaining nerve fibers in the striatum is a pathological hallmark of Parkinson's disease (PD).
The cause and underlying mechanism responsible for the progressive neurodegeneration of sporadic PD remain unclear (Olanow and Tatton, 1999) .
Inflammation in the brain, characterized by the activation of microglia and astroglia, has been closely associated with the pathogenesis of PD, as well as with several other degenerative neurological disorders, including Alzheimer's disease (McGeer et al., 1988; McGeer and McGeer, 1988; Dickson et al., 1993; Giulian 1999; Liu and Hong, 2002) . Microglia, the resident immune cells in the brain, serve the role of immune surveillance under normal conditions (Kreutzberg, 1996) . Under pathological conditions, microglia become activated and produce a variety of factors including cytokines and reactive oxygen and nitrogen species. Accumulation of these proinflammatory and cytotoxic factors is deleterious to neurons (Chao et al., 1992; Boje and Arora 1992; Jeohn et al., 1998; McGuire et al., 2001; Liu et al., 2002) . Dopaminergic neurons, in particular, are especially vulnerable to oxidative damage due to their reduced anti-oxidant capacity and potential defect in mitochondrial function (Jenner and Olanow, 1996; Greenamyre et al., 1999) . Since the midbrain region that encompasses the SN is particularly rich in microglia (Lawson et al., 1990; Kim et al., 2000) , activation of nigral microglia and release of neurotoxic factors may be a crucial component of the degenerative process of dopaminergic neurons in PD.
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In the mesencephalic mixed neuron-glia cultures, stimulation of microglia with an inflammagen lipopolysaccharide (LPS) induces the production of factors that include tumor necrosis factor-alpha (TNFα), interleukin 1-beta (IL-1β), nitric oxide (NO) and superoxide. Studies have attributed the accumulation of those factors to the degeneration of dopaminergic neurons (Kim et al., 2000; Liu et al., 2000a; Gayle et al., 2002; Gao et al., 2002a; Liu et al., 2002) . Intranigral infusion or in utero administration of LPS in rats results in significant degeneration of nigral dopaminergic neurons and depletion of the striatal content of dopamine (Castano et al. 1998; Lu et al., 2000; Liu et al., 2002b; Ling et al., 2002 , Gao et al., 2002b . Therefore, those in vitro and in vivo models of inflammation-mediated dopaminergic neurodegeneration are powerful tools for mechanistic studies and the identification of potential therapeutic agents.
DM is a dextrorotatory morphinan and is widely used as a non-opioid cough suppressant in a variety of over-the-counter remedies (Tortella et al., 1989) . The exact mechanism of action of its antitussive activity, however, remains unclear.
Nevertheless, studies using animal models of cerebral ischemia and hypoglycemic neural injuries have demonstrated that DM possesses neuroprotective activity (Steinberg et al., 1988; George et al., 1988; Prince and Feeser, 1988; Monyer and Choi, 1988; Britton et al., 1997; Tortella et al., 1999) . Attempts to attribute the neuroprotective activity of DM to antagonism of glutamate receptors have been complicated by conflicting reports about its ability to prevent glutamate excitatory toxicity (Choi 1987; DeCoster et al., 1995; Lesage et al., 1995; Berman and Murray, 1996; Haberecht et al., 7 1997) . Nevertheless, the effect of DM on the degeneration of dopaminergic neurons has not been studied.
In this study, using primary mesencephalic neuron-glia cultures, we demonstrated that DM significantly reduced the LPS-induced degeneration of dopaminergic neurons.
The neuroprotective effect of DM was related to its inhibition of the LPS-induced activation of microglia and the production of TNFα, NO and superoxide.
9 sodium pyruvate, 100 µM non-essential amino acids, 50 U/ml penicillin, and 50 µg/ml streptomycin. Three days after the initial seeding, 0.5 ml of fresh maintenance medium was added to each well. For superoxide assays, 10 5 cells in 0.1 ml of maintenance medium were seeded to each well of poly-D-lysine-coated 96-well culture plates with 0.1 ml/well fresh maintenance medium supplemented 3 days later. Seven-day-old cultures were used for treatment. The composition of the cultures at the time of treatment was approximately 48% astrocytes, 11 % microglia, 40 % neurons and ~0.5%
TH-immunoreactive (ir) neurons.
Primary mesencephalic neuron-enriched cultures. Midbrain neuron-enriched cultures
were established as previously described (Gao et al., 2002a; Qin et al., 2002) . Briefly, 24
h after seeding the cells, cytosine β-D-arabinofuranoside was added to a final concentration of 10 µM to suppress glial proliferation. Three days later, cultures were changed back to maintenance medium and were used for treatment 7 days after initial seeding.
Primary microglia-enriched cultures. Rat microglia-enriched cultures, with a purity of >98%, were prepared from whole brains of 1-day old Fisher 344 rat pups, following our previously described protocol (Liu et al., 2002; Qin et al., 2002) . For superoxide assays, 10 5 cells/well/0.2 ml medium were grown overnight in 96-well culture plates before use.
This article has not been copyedited and formatted. The final version may differ from this version. Immunostaining. Dopaminergic neurons were recognized with the anti-TH antibody and microglia were detected with the OX-42 antibody, which recognizes the CR3 receptor as previously described (Liu et al., 2002; Qin et al., 2002 Xanthine oxidase (XO) activity. To determine whether DM acts as a superoxide scavenger, the superoxide-generating xanthine/XO system was used (McCord and Fredovich, 1968) . Briefly, DM, XO (10 mU, sigma), WST-1 (1 mM) were mixed in potassium phosphate buffer (50 mM, pH 7.6) in a quartz cuvette (1 cm). Xanthine (50 µM final concentration) was added to initiate the reaction (final volume, 1 ml).
Absorbence at 450 nm was continuously monitored at 5-second intervals for 3 minutes.
Results are expressed as a percentage of the increase in absorbance/min observed with XO only.
Statistical analysis. The data were expressed as the mean ± SEM. Statistical significance was assessed with an analysis of variance (ANOVA) followed by Bonferroni's t test using the StatView program (Abacus Concepts, Inc., Berkeley, CA).
A value of p < 0.05 was considered statistically significant.
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RESULTS

Effect of DM on LPS-induced degeneration of dopaminergic neurons
Mesencephalic neuron-glia cultures were pretreated for 30 min with vehicle or 1-10 µM DM prior to treatment with 10 ng/ml LPS. Seven days later, the degeneration of dopaminergic neurons was assessed. Morphologically, in addition to the reduction in abundance of TH-ir neurons, the dendrites of the remaining TH-ir neurons in the LPS-treated cultures was significantly less elaborate than that of the control cultures (Fig. 2) . In cultures pretreated with DM (10 µM) prior to LPS stimulation, TH-ir neurons were significantly more numerous with the TH-ir dendrites less affected compared to the LPS-treated cultures (Fig. 2 ).
While the average dendrite length of TH-ir neurons in the LPS-treated cultures was
This article has not been copyedited and formatted. The final version may differ from this version. In addition to the determination of the effect of pre-treatment with DM on the LPS-induced dopaminergic neurodegeneration, the effect of post-treatment was also examined. To this end, neuron-glia cultures were either treated with DM (10 µM) and LPS (10 ng/ml) at the same time or DM (10 µM final concentration) was added 30, 60, 120 or 180 min after the addition of LPS (10 ng/ml). Seven days later, DA uptake of the cultures was determined. Significant neuroprotection was observed in cultures with DM added up to 60 min after the addition of LPS (Fig. 3) .
Effect of DM on neurodegeneration induced by MPP + or Aβ (1-42)
To investigate whether the neuroprotective activity of DM was dependent on the presence of glial cells, we determined the effect of DM on the degeneration of dopaminergic neurons in neuron-enriched cultures following treatment with MPP + or Aβ (1-42). As shown in Figure 4 , 5 days after treatment with 2 µM MPP + or 8 µM Aβ (1-42), DA uptake was reduced by 92% and 60%, respectively, compared to the control cultures. Pretreatment of the neuronal cultures with 10 µM DM prior to MPP + or Aβ (1-42) did not significantly alter the magnitude of the MPP + -or Aβ (1-42)-induced reduction in DA uptake (Fig. 4) . These results suggested that the neuroprotective effect of DM was mediated through the activity of glial cells.
Activation of glia, especially that of microglia, mediates the LPS-induced neurodegeneration (Bronstein et al., 1995; Araki et al., 2001; Gao et al., 2002b) .
This article has not been copyedited and formatted. The final version may differ from this version. Activated microglia secrete a variety of neurotoxic factors and TNFα, NO and superoxide appear to be key mediators of dopaminergic neurodegeneration (Liu et al., 2000a; McGuire et al., 2001; Gao et al., 2002b; Gayle et al., 2002; Liu et al., 2002; Qin et al., 2002) . Therefore, we determined the effect of DM on the LPS-stimulated production of TNFα, NO and superoxide in neuron-glia or microglia-enriched cultures. Release of TNFα from neuron-glia cultures was determined at 6, 24, and 48 h after LPS stimulation. As shown in Fig. 5A , the amount of TNFα in cultures pretreated with 10 µM DM decreased by 22-24% compared to cultures treated with LPS alone (Fig. 5A ).
Accumulation of nitrite, an indicator of LPS-stimulated production of NO, was determined at 24, 48, and 72 hr following LPS stimulation. As shown in Fig. 5B , in cultures pretreated with 10 µM DM prior to stimulation with LPS, the level of NO was reduced by 30-41 % between the 24-and 72-h time points (Fig. 5B ).
The effect of DM on LPS-stimulated production of superoxide was determined in both the neuron-glia and microglia-enriched cultures. As shown in Fig. 6A , DM dose-dependently inhibited the LPS-stimulated production of superoxide in neuronglia cultures. Significant inhibition was observed in cultures pretreated with 2.5-10 µM DM and a near complete inhibition of LPS-stimulated superoxide production was observed in cultures pretreated with 10 µM DM (Fig. 6A) . In microglia-enriched cultures, pretreatment with 1-10 µM DM significantly inhibited LPS-stimulated production of superoxide (Fig. 6B) .
Effect of DM on superoxide generation by xanthine/XO
This article has not been copyedited and formatted. The final version may differ from this version. The xanthine/XO superoxide-generating system has been widely used to determine the superoxide scavenging activity of agents of interest (Wang et al., 1999) .
The production of superoxide by the xanthine/XO system was very sensitive to the presence of SOD (Fig. 7A) . However, DM (1-10 µM) did not have any effect on the xanthine/XO-driven superoxide generation capacity (Fig. 7B) , indicating that at 1-10 µM, DM did not act as a superoxide scavenger.
This article has not been copyedited and formatted. The final version may differ from this version. may be highly relevant to the development of potential therapeutic agents. In our studies, we have shown that the production of NO, TNFα and superoxide by LPSactivated microglia is significantly inhibited by DM and inhibition of the production of these factors confers significant protection to dopaminergic neurons against inflammation-mediated degeneration.
In this study, DM appears to be significantly more potent in inhibiting LPSinduced superoxide production than the production of NO and TNFα (Figs. 5 and 6 ).
The DM-induced reduction in superoxide was due to an inhibition of production but not scavenging of the superoxide free radical (Fig. 7) . This result may imply that LPSinduced superoxide generation may play a more critical role than other microgliaoriginated factors in the induction of dopaminergic neurodegeneration. In fact, in mesencephalic neuron-glia cultures stimulated with very low concentrations of LPS (<1 ng/ml), production of superoxide, but not NO and TNFα, appears to mediate LPSinduced dopaminergic neurotoxicity (Gao et al., 2002a) . Interestingly, both the pesticide rotenone and Aβ (1-42) exhibited significantly enhanced neurotoxicity toward mesencephalic or cortical neurons in the presence of microglia. The elevated neurotoxicity was attributed to the activation of microglia and production of superoxide free radicals (Gao et al., 2002b; Qin et al., 2002) Downloaded from DM appears to be similar to that of naloxone stereoisomers. Naloxone is more effective in the inhibition of superoxide generation than TNFα, NO or IL-1β (Simpkins et al., 1985; Chang et al., 2000; Liu et al., 2000a , Liu et al., 2002 . The neuroprotective effect of naloxone has been observed in both the in vitro and in vivo models of inflammationmediated neurodegeneration (Lu et al., 2000; Liu et al., 2000a Liu et al., , 2000b Liu et al., 2002) . It will be important to determine whether the neuroprotective effect of DM can be observed in animal models of inflammation-mediated neurodegenerative diseases.
Over the years, a number of studies have reported that DM has neuroprotective effects (Choi 1987; Steinberg et al., 1988; George et al., 1988; Prince and Feeser, 1988; Monyer and Choi, 1988; Britton et al., 1997 , DeCoster et al., 1995 Lesage et al., 1995; Berman and Murray, 1996; Haberecht et al., 1997) . The mechanism of action responsible for this neuroprotective activity has been attributed to DM's potential antagonistic effect on the NMDA receptor complex. However, the discovery of high (nM) and low (µM) affinity binding sites for DM in the CNS has made it more difficult to explain many of its observed beneficial effects (Craviso and Musacchio, 1983a and 1983b) . In this study, the neuroprotective effect of DM was most likely mediated by the inhibition of LPS-induced microglial activation and production of neurotoxic factors of glutamate as high as 100-1000 µM are required to induce significant neuronal death (Obrenovitch et al., 2000) . Furthermore, MK801, an effective NMDA antagonist, failed to afford significant protection against LPS-induced dopaminergic neurodegeneration (data not shown). Therefore, it is unlikely that the neuroprotective effect of DM is mediated by a blockade of NMDA receptors.
In addition to the inhibition of superoxide generation, DM was also capable of reducing NO production. Preliminary studies indicated that the inhibitory effect on NO production appeared to be due to a direct effect of DM on the enzymatic activity of inducible nitric oxide synthase but not on LPS-induced expression of iNOS gene in microglia (data not shown). Furthermore investigation on the precise mechanism of action responsible for the inhibitory effect of DM on superoxide generation, NO synthesis, and TNFα release are certainly warranted. Nevertheless, the observation that DM is capable of inhibiting LPS-induced microglial activation and reducing the production of proinflammatory and cytotoxic factors may provide insight into the potential novel effect of DM as a neuroprotective agent.
